Monday, October 26, 2026 · Daily editionET --:--:--

Finished

A Study Testing Safety and Tolerance of the ReWalk Exoskeleton Suit

NCT00627107 · ReWalk Robotics, Inc. · Updated 30 Nov 2010

What is being tested
ReWalk - a motorized exoskeleton suit
For
Paraplegia; SCI
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 55 years. About 6 people. The full rules are on the registry page.
Where
Israel
When
Starts or started Feb 2008, ends Jan 2009. Registered 29 Feb 2008.
Results
None posted yet.

In the researchers' words

The ReWalk enables people with lower limb disabilities to carry out routine ambulatory functions (stand, walk, climb stairs etc.). It can be used by people with disabilities such as spinal cord injury, brain injury, stroke, multiple sclerosis, cerebral palsy and other severe walking impairments. The device promises to restore the dignity of disabled persons, enabling them to work and improve their general health and quality of life, as well as significantly reduce medical and other related expenses.
ClinicalTrials.gov, NCT00627107

Sites

  • Sheba Medical Center, Neurological Rehabilitation DepartmentTel Litwinsky, Israel